Yi Jing, Lu Li, Yanger Kilangsungla, Wang Wenqi, Sohn Bo Hwa, Stanger Ben Z, Zhang Min, Martin James F, Ajani Jaffer A, Chen Junjie, Lee Ju-Seog, Song Shumei, Johnson Randy L
Department of Cancer Biology, MD Anderson Cancer Center, University of Texas, Houston, TX.
Department of Genetics, MD Anderson Cancer Center, University of Texas, Houston, TX.
Hepatology. 2016 Nov;64(5):1757-1772. doi: 10.1002/hep.28768. Epub 2016 Sep 30.
In the adult liver, the Hippo pathway mammalian STE20-like protein kinases 1 and 2 and large tumor suppressor homologs 1 and 2 (LATS1/2) control activation of the transcriptional coactivators Yes-associated protein (YAP) and WW domain containing transcription regulator 1 (TAZ) in hepatocytes and biliary epithelial cells, thereby regulating liver cell proliferation, differentiation, and malignant transformation. Less is known about the contribution of Hippo signaling to liver development. We used conditional mutagenesis to show that the Hippo signaling pathway kinases LATS1 and LATS2 are redundantly required during mouse liver development to repress YAP and TAZ in both the biliary epithelial and hepatocyte lineages. In the absence of LATS1/2, biliary epithelial cells exhibit excess proliferation while hepatoblasts fail to mature into hepatocytes, defects that result in perinatal lethality. Using an in vitro hepatocyte differentiation assay, we demonstrate that YAP activity decreases and Hippo pathway kinase activities increase upon differentiation. In addition, we show that YAP activation in vitro, resulting from either depletion of its negative regulators LATS1/2 or expression of a mutant form of YAP that is less efficiently phosphorylated by LATS1/2, results in transcriptional suppression of genes that normally accompany hepatocyte maturation. Moreover, we provide evidence that YAP activity is repressed by Hippo pathway activation upon hepatocytic maturation in vitro. Finally, we examine the localization of YAP during fetal liver development and show that higher levels of YAP are found in biliary epithelial cells, while in hepatocytes YAP levels decrease with hepatocyte maturation.
Hippo signaling, mediated by the LATS1 and LATS2 kinases, is required to restrict YAP and TAZ activation during both biliary and hepatocyte differentiation. These findings suggest that dynamic regulation of the Hippo signaling pathway plays an important role in differentiation and functional maturation of the liver. (Hepatology 2016;64:1757-1772).
在成年肝脏中,Hippo信号通路中的哺乳动物STE20样蛋白激酶1和2以及大肿瘤抑制因子同源物1和2(LATS1/2)控制肝细胞和胆管上皮细胞中转录共激活因子Yes相关蛋白(YAP)和含WW结构域的转录调节因子1(TAZ)的激活,从而调节肝细胞增殖、分化和恶性转化。关于Hippo信号对肝脏发育的贡献了解较少。我们利用条件性诱变表明,在小鼠肝脏发育过程中,Hippo信号通路激酶LATS1和LATS2在胆管上皮和肝细胞谱系中对抑制YAP和TAZ具有冗余需求。在缺乏LATS1/2的情况下,胆管上皮细胞表现出过度增殖,而成肝细胞无法成熟为肝细胞,这些缺陷导致围产期致死。利用体外肝细胞分化试验,我们证明分化时YAP活性降低,Hippo信号通路激酶活性增加。此外,我们表明,体外YAP激活,无论是由于其负调节因子LATS1/2的缺失,还是由于表达一种被LATS1/2磷酸化效率较低的YAP突变形式,都会导致通常伴随肝细胞成熟的基因的转录抑制。此外,我们提供证据表明,体外肝细胞成熟时,Hippo信号通路激活会抑制YAP活性。最后,我们检查了YAP在胎儿肝脏发育过程中的定位,结果显示胆管上皮细胞中YAP水平较高,而在肝细胞中,YAP水平随着肝细胞成熟而降低。
由LATS1和LATS2激酶介导的Hippo信号在胆管和肝细胞分化过程中对限制YAP和TAZ激活是必需的。这些发现表明,Hippo信号通路的动态调节在肝脏的分化和功能成熟中起重要作用。(《肝脏病学》2016年;64:1757 - 1772)